List of Figures:
Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2005-2008
Figure 2-2: Global - Forecast for Pharmaceutical Market (Billion US$), 2009-2012
Figure 2-3: G7 Countries - Pharmaceutical Market (Billion US$), 2008
Figure 2-4: G7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2012
Figure 2-5: G7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2009 to 2012
Figure 2-6: E7 Countries - Pharmaceutical Market (Billion US$), 2008
Figure 2-7: E7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2012
Figure 2-8: E7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2009 to 2012
Figure 2-9: Global - Share of E7 & G7 Countries in Pharmaceutical Market (2008 & 2012)
Figure 3-1: G7 Countries - Real GDP (Trillion US$), 2004 & 2012
Figure 3-2: E7 Countries - Real GDP (Trillion US$), 2004 & 2012
Figure 3-3: Global - Share of E7 & G7 Countries in Population (2007 & 2012)
Figure 3-4: Relative Per Capita Spending on Drugs by Age Group
Figure 4-1: Brazil - Nominal GDP (Billion US$), 2007-2012
Figure 4-2: Brazil - Consumer Price Index (%), 2007-2012
Figure 4-3: Brazil - Currency Exchange Rate (From US$ to BRL), 2007-2012
Figure 4-4: Brazil - Foreign Direct Investment (Billion US$), 2005-2008
Figure 4-5: Brazil - Population (Million), 2006-2012
Figure 4-6: Brazil - Breakup of Population by Age Group (%), 2006-2012
Figure 4-7: Brazil - Population in the Age Group of 65 Years & Above (Million), 2006-2012
Figure 4-8: Brazil - Number of Deaths due to Leading Causes (‘000)
Figure 4-9: Brazil - Breakup of Deaths by Various Causes (%), 2008
Figure 4-10: Brazil - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-11: Brazil - Breakup of Healthcare Payment by Source (%), 2008
Figure 4-12: Brazil - Pharmaceutical Market (Billion US$), 2007-2012
Figure 4-13: Brazil - Pharmaceutical Imports (Billion US$), 2005-2008
Figure 4-14: Brazil - Pharmaceutical Exports (Million US$), 2005-2008
Figure 4-15: Brazil - Generic Drugs Market (Million US$), 2006-2012
Figure 4-16: Brazil - Share of Generic Drugs in Pharmaceutical Market (2008 & 2012)
Figure 4-17: Brazil - Pharmaceutical Market by Segment (%), 2008
Figure 4-18: Russia - Nominal GDP (Billion US$), 2007-2012
Figure 4-19: Russia - Consumer Price Index (%), 2007-2012
Figure 4-20: Russia - Foreign Direct Investment (Billion US$), 2005-2008
Figure 4-21: Russia - Population (Million), 2007-2012
Figure 4-22: Russia - Breakup of Population by Age Group (%), 2007-2012
Figure 4-23: Russia - Population in the Age Group of 65 Years & Above (Million), 2007-2012
Figure 4-24: Russia - Number of Deaths due to Leading Causes ('000)
Figure 4-25: Russia - Breakup of Deaths by Various Causes (%), 2008
Figure 4-26: Russia - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-27: Russia - Breakup of Healthcare Payment by Source (%), 2008
Figure 4-28: Russia - Pharmaceutical Market (Billion Rubles), 2007-2012
Figure 4-29: Russia - Pharmaceutical Imports (Billion Rubles), 2007 & 2008
Figure 4-30: Russia - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 4-31: India - Nominal GDP (Billion US$), 2007-2012
Figure 4-32: India - Consumer Price Index (%), 2007-2012
Figure 4-33: India - Foreign Direct Investment (Billion US$), 2006-07 to 2008-09
Figure 4-34: India - Foreign Direct Investment in Pharmaceutical Market (Million US$), 2006-07 to 2008-09
Figure 4-35: India - Population (Million), 2006-2012
Figure 4-36: India - Breakup of Population by Age Group (%), 2006-2012
Figure 4-37: India - Population in the Age Group of 65 Years & Above (Million), 2006-2012
Figure 4-38: India - Number of Deaths due to Leading Causes ('000)
Figure 4-39: India - Breakup of Deaths by Various Causes (%), 2008
Figure 4-40: India - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-41: India - Breakup of Healthcare Payment by Source (%), 2006
Figure 4-42: India - Pharmaceutical Market (Billion INR), 2006-07 to 2012-13
Figure 4-43: India - Pharmaceutical Imports (Billion INR), 2006-07 to 2012-13
Figure 4-44: India - Pharmaceutical Exports (Billion INR), 2006-07 to 2012-13
Figure 4-45: India - Forecast for Breakup of Domestic Pharmaceutical Market by Segment (%), 2010
Figure 4-46: China - Nominal GDP (Billion US$), 2007-2012
Figure 4-47: China - Consumer Price Index (%), 2007-2012
Figure 4-48: China - Foreign Direct Investment (Billion US$), 2005-2008
Figure 4-49: China - Population (Million), 2007-2012
Figure 4-50: China - Breakup of Population by Age Group (%), 2007-2012
Figure 4-51: China - Population in the Age Group of 65 Years & Above (Million), 2007-2012
Figure 4-52: China - Number of Deaths due to Leading Causes ('000)
Figure 4-53: China - Breakup of Deaths by Various Causes (%), 2008
Figure 4-54: China - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-55: China - Breakup of Healthcare Payment by Source (%), 2006
Figure 4-56: China - Pharmaceutical Market (Billion US$), 2007-2012
Figure 4-57: China - TCM Market (Billion CNY), 2005-2008
Figure 4-58: China - Pharmaceutical Purchase by Source (%)
Figure 4-59: China - Medicine & Health Product Imports (Billion US$), 2005-2007
Figure 4-60: China - Breakup of Medicine & Health Product Imports by Type (%), 2006
Figure 4-61: China - Medicine & Health Product Exports (Billion US$), 2005-2007
Figure 4-62: China - Breakup of Medicine & Health Product Exports by Type (%), 2006
Figure 4-63: China - Pharmaceutical Market by Type of Drug (%), 2007
Figure 4-64: Turkey - Nominal GDP (Billion US$), 2007-2012
Figure 4-65: Turkey - Consumer Price Index (%), 2007-2012
Figure 4-66: Turkey - Foreign Direct Investment (Billion US$), 2006-2008
Figure 4-67: Turkey - Population (Million), 2006-2012
Figure 4-68: Turkey - Breakup of Population by Age Group (%), 2006-2012
Figure 4-69: Turkey - Population in the Age Group of 65 Years & Above (Million), 2006-2012
Figure 4-70: Turkey - Number of Deaths due to Leading Causes ('000)
Figure 4-71: Turkey - Breakup of Deaths by Various Causes (%), 2008
Figure 4-72: Turkey - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-73: Turkey - Breakup of Healthcare Payment by Source (%)
Figure 4-74: Turkey - Pharmaceutical Market (Billion US$), 2007-2012
Figure 4-75: Turkey - Pharmaceutical Market (Million Boxes), 2006-2008
Figure 4-76: Turkey - Share of Imported & Domestically Manufactured Drugs in Pharmaceutical Market (2008)
Figure 4-77: Turkey - Pharmaceutical Exports (Million US$), 2006-2008
Figure 4-78: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 4-79: Turkey - Share of Branded & Generic Drugs Sales Volume in Pharmaceutical Market (2008)
Figure 4-80: Mexico - Nominal GDP (Billion US$), 2007-2012
Figure 4-81: Mexico - Consumer Price Index (%), 2007-2012
Figure 4-82: Mexico - Foreign Direct Investment (Billion US$), 2006-2008
Figure 4-83: Mexico - Population (Million), 2006-2012
Figure 4-84: Mexico - Breakup of Population by Age Group (%), 2006-2012
Figure 4-85: Mexico - Population in the Age Group of 65 Years & Above (Million), 2006-2012
Figure 4-86: Mexico - Number of Deaths due to Leading Causes ('000)
Figure 4-87: Mexico - Breakup of Deaths by Various Causes (%), 2008
Figure 4-88: Mexico - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-89: Mexico - Breakup of Healthcare Payment by Source (%)
Figure 4-90: Mexico - Pharmaceutical Market (Billion US$), 2007-2012
Figure 4-91: Mexico - Pharmaceutical Imports (Billion US$), 2003 & 2007
Figure 4-92: Mexico - Pharmaceutical Exports (Billion US$), 2003, 2006 & 2007
Figure 4-93: Mexico - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 4-94: Mexico - Share of Top Players in Pharmaceutical Market (2007)
Figure 4-95: Indonesia - Nominal GDP (Billion US$), 2007-2012
Figure 4-96: Indonesia - Consumer Price Index (%), 2007-2012
Figure 4-97: Indonesia - Foreign Direct Investment (Billion US$), 2006-2008
Figure 4-98: Indonesia - Population (Million), 2007-2012
Figure 4-99: Indonesia - Breakup of Population by Age Group (%), 2007-2012
Figure 4-100: Indonesia - Population in the Age Group of 65 Years & Above (Million), 2007-2012
Figure 4-101: Indonesia - Number of Deaths due to Leading Causes ('000), 2005
Figure 4-102: Indonesia - Breakup of Deaths by Various Causes (%), 2008
Figure 4-103: Indonesia - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-104: Indonesia - Breakup of Healthcare Payment by Source (%), 2008
Figure 4-105: Indonesia - Pharmaceutical Market (Trillion Rp), 2007-2012
Figure 4-106: Indonesia - Share of OTC & Prescription Drugs in Pharmaceutical Market (2008)
Figure 4-107: Indonesia - Pharmaceutical Exports (Million US$) 2004-2007
Figure 4-108: Indonesia - Pharmaceutical Imports (Million US$) 2004-2007
Figure 4-109: Indonesia - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 4-110: Indonesia - Share of Top Players in Prescription Pharmaceutical Market (Q1 2009)
Figure 4-111: Indonesia - Share of Top Players in OTC Pharmaceutical Market (Q1 2009)
Figure 5-1: Global - Pharma Outsourcing Market by Segment (%), 2006
Figure 5-2: BRIC Countries - Medical Device Market (Million US$), 2006
List of Tables:
Table 2-1: Global - Pharmaceutical Market by Region (Billion US$), 2008
Table 3-1: E7 Countries - Disposable Income (Million US$), 2007 & 2012
Table 3-2: G7 Countries - Population (Million), 2007 & 2012
Table 3-3: E7 Countries - Population (Million), 2007 & 2012
Table 3-4: G7 Countries - Population in the Age Group of 65 Years & Above (Million), 2007 & 2012
Table 3-5: E7 Countries - Population in the Age Group of 65 Years & Above (Million), 2007 & 2012
Table 4-1: Brazil - Performance of Top 10 Players in Pharmaceutical Market (2006)
Table 4-2: Russia - Performance of Key Players in Pharmaceutical Market (2008)
Table 4-3: India - Performance of Drugs by Therapeutic Segment in Domestic Pharmaceutical Market
Table 4-4: India - Performance of Top 10 Pharmaceutical Players (2008)
Table 4-5: China - Performance of Drugs by Key Therapeutic Segment in Pharmaceutical Market (2005 & 2006)
Table 4-6: China - Performance of Key Players in Pharmaceutical Market (H1 2006 & H1 2007)
Table 4-7: Turkey - Performance of Key Therapy Areas in Pharmaceutical Market (2008)
Table 4-8: Turkey - Top 20 Pharmaceutical Players by Sales (Million US$), Jan-Sep 2007
Table 4-9: Turkey - Top 20 Pharmaceutical Players by Sales Volume (Million Units), Jan-Sep 2007
Table 4-10: Mexico - Performance of Therapy Areas in Retail Pharmaceutical Market (2006)
Table 5-1: India - Market for Various Chronic Diseases (Billion INR), 2006 & 2010
Table 5-2: India, China & Brazil - Vaccine Market (Million US$), 2006 & 2010
Table 7-1: GlaxoSmithKline plc - Strengths & Weaknesses
Table 7-2: Sanofi-Aventis - Strengths & Weaknesses
Table 7-3: Pfizer Inc - Strengths & Weaknesses
Table 7-4: Novartis - Strengths & Weaknesses
Table 7-5: AstraZeneca - Strengths & Weaknesses
